Amazon Announces $50 Bn AI Investment to Boost Healthcare Research

The company said its investment is aligned with the White House’s AI Action Plan, which focuses on expanding the adoption of AI across national research programmes.

Amazon has unveiled plans to invest up to $50 billion to expand AI and supercomputing infrastructure for U.S. federal agencies, opening the door to faster healthcare research, advanced drug discovery, and large-scale scientific innovation.

The company said the rollout will begin with new data centres scheduled for construction in 2026. These facilities will provide Amazon Web Services’ U.S. government customers with an additional 1.3 gigawatts of AI and high-performance computing capacity, significantly expanding access to advanced tools used in biomedical modelling, large dataset analysis, and pharmaceutical R&D.

“We’re giving agencies expanded access to advanced AI capabilities that will enable them to accelerate critical missions from cybersecurity to drug discovery,” Amazon Web Services CEO Matt Garman said in a press release.

“This investment removes the technology barriers that have held government back and further positions America to lead in the AI era,” he added.

Amazon announced the plan on the same day President Donald Trump signed an executive order urging federal agencies to work closely with the private sector on AI-driven scientific progress.

The company said its investment is aligned with the White House’s AI Action Plan, which focuses on expanding the adoption of AI across national research programmes.

The $50 billion commitment marks one of Amazon’s largest efforts to support government-led innovation. For healthcare, the added supercomputing power is expected to strengthen data-intensive research areas such as genomics, precision medicine, drug development, and AI-based clinical decision-support tools.

Stay tuned for more such updates on Digital Health News